Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank42
Studio
Year-over-Year Change

Free cash flow yield

Latest
-12.76%
↑ 63% vs avg
Percentile
P42
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-34.08%
Historical baseline
PeriodValueYoY Change
2025-12.76%-21.1%
2024-10.54%+90.3%
2023-108.64%-1536.9%
2022-6.64%-4.4%
2021-6.36%+55.2%
2020-14.20%+88.7%
2019-125.55%-198.9%
2018-42.01%-420.8%
2017-8.07%-34.6%
2016-5.99%-